The assay assesses 5 CpG sites within exon 1 of the tumour suppressor gene MGMT, and interrogates a cytosine nucleotide not followed by a guanine in exon 1 to determine bisulfite conversion. The gene discussed is MGMT; the disease is neoplasm.